Daklinza (daclatasvir) / BMS  >>  Phase 3
Welcome,         Profile    Billing    Logout  

3 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Daklinza (daclatasvir) / BMS
NCT04497649: Sofosbuvir Containing Regimens in Treatment of COVID 19 Patients

Recruiting
2/3
100
RoW
Sofosbuvir, Mpiviropack, Sovaldy, soflanork, Daclatasvir, daklinza, daklanork
Tanta University
Covid19
04/21
04/21
NCT04460443: Sofosbuvir in Treatment of COVID 19

Recruiting
2/3
60
RoW
sofosbuvir, Mpiviropack, Sovaldy, soflanork, Sofosbuvir ledipsavir, mpiviropack plus, Daclatasvir, daklinza
Tanta University
COVID
08/21
08/21
REVOLUTIOn, NCT04468087: Antiviral Agents Against COVID-19 Infection

Completed
2/3
256
RoW
Atazanavir, Active Group, Daclatasvir 60 mg, Sofusbuvir + Daclastavir 60 mg, Placebo Atazanavir, Placebo group, Placebo Daclatasvir 60 mg, Placebo Sofusbuvir + Daclatasvir 60 mg
Hospital do Coracao
COVID-19
08/21
08/21

Download Options